1. Home
  2. HNVR vs MSLE Comparison

HNVR vs MSLE Comparison

Compare HNVR & MSLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hanover Bancorp Inc.

HNVR

Hanover Bancorp Inc.

SELL

Current Price

$23.33

Market Cap

153.5M

Sector

Finance

ML Signal

SELL

MSLE

Satellos Bioscience Inc. Common Stock

N/A

Current Price

$5.85

Market Cap

146.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
HNVR
MSLE
Founded
2008
N/A
Country
United States
Canada
Employees
N/A
17
Industry
Commercial Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
153.5M
146.9M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
HNVR
MSLE
Price
$23.33
$5.85
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$24.50
N/A
AVG Volume (30 Days)
71.5K
28.2K
Earning Date
04-27-2026
N/A
Dividend Yield
1.72%
N/A
EPS Growth
N/A
N/A
EPS
0.25
N/A
Revenue
N/A
N/A
Revenue This Year
$35.49
N/A
Revenue Next Year
$8.61
N/A
P/E Ratio
$93.12
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.91
$5.50
52 Week High
$24.55
$13.39

Technical Indicators

Market Signals
Indicator
HNVR
MSLE
Relative Strength Index (RSI) 49.43 37.81
Support Level $21.89 $5.56
Resistance Level $24.27 $8.59
Average True Range (ATR) 0.84 0.38
MACD -0.07 -0.03
Stochastic Oscillator 50.29 6.10

Price Performance

Historical Comparison
HNVR
MSLE

About HNVR Hanover Bancorp Inc.

Hanover Bancorp Inc is a community commercial bank focused on providing personalized and efficient services and products tailored to local needs. The Bank offers a full range of financial services, including a complete suite of consumer, commercial, and municipal banking products such as multifamily and commercial mortgages, government-guaranteed loans, residential loans, business loans, and lines of credit. In addition, it provides customers with access to 24-hour ATM services with no fees, interest-bearing free checking accounts, telephone banking, mobile and internet banking solutions for both consumer and business clients, and safe deposit boxes.

About MSLE Satellos Bioscience Inc. Common Stock

Satellos Bioscience Inc is a regenerative medicine company a biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.

Share on Social Networks: